Let's throw a wrench at management and try to destroy it just before landing contracts with 4 commited customers. Brilliant! NOT.

Breeze this is a pre-revenue company, what's important is getting through qualifications of the Betas and land those contracts. Replacing TM won't make the Betas go quicker, won't make the contracts land quicker, but will surely notify our customers and partners that we have an insane (literally, medically) shareholder base.

Why are you pointing fingers everywhere except the elephant in the room? The market is simply waiting for commercial progress.